The present invention relates to a chemically modified heparin, with an antifactor II activity of less than 10 IU/mg, an antifactor Xa activity of less than 10 IU/mg and an average molecular weight (Mw) between about 6.5 and 9.5 kDa. Also disclosed is a method of preparing the heparin and its medical use, including treatment of malaria.
展开▼
机译：化学修饰的肝素本发明涉及化学修饰的肝素，其抗因子II活性小于10 IU / mg，抗Xa活性小于10 IU / mg，平均分子量（Mw）在约6.5至9.5 kDa之间。还公开了制备肝素的方法及其医学用途，包括治疗疟疾。
展开▼
